La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Vita Life Sciences Performance dei guadagni passati

Il passato criteri di controllo 6/6

Vita Life Sciences has been growing earnings at an average annual rate of 23.9%, while the Pharmaceuticals industry saw earnings growing at 35.6% annually. Revenues have been growing at an average rate of 13.6% per year. Vita Life Sciences's return on equity is 21%, and it has net margins of 12.2%.

Informazioni chiave

23.9%

Tasso di crescita degli utili

24.1%

Tasso di crescita dell'EPS

Pharmaceuticals Crescita del settore	31.2%
Tasso di crescita dei ricavi	13.6%
Rendimento del capitale proprio	21.0%
Margine netto	12.2%
Ultimo aggiornamento sui guadagni	31 Dec 2023

Aggiornamenti sulle prestazioni recenti

Recent updates

Vita Life Sciences Limited (ASX:VLS) Stock Catapults 26% Though Its Price And Business Still Lag The Market

Mar 22

Vita Life Sciences (ASX:VLS) Has Announced That It Will Be Increasing Its Dividend To A$0.06

Mar 14

Vita Life Sciences' (ASX:VLS) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 28

A Look At The Fair Value Of Vita Life Sciences Limited (ASX:VLS)

Dec 20

Should You Be Adding Vita Life Sciences (ASX:VLS) To Your Watchlist Today?

Aug 24

If You Like EPS Growth Then Check Out Vita Life Sciences (ASX:VLS) Before It's Too Late

May 14

Did Vita Life Sciences' (ASX:VLS) Share Price Deserve to Gain 83%?

Mar 18

Vita Life Sciences Limited (ASX:VLS) On An Uptrend: Could Fundamentals Be Driving The Stock?

Feb 17

Vita Life Sciences (ASX:VLS) Is Growing Earnings But Are They A Good Guide?

Jan 20

Here's Why We Think Vita Life Sciences (ASX:VLS) Is Well Worth Watching

Dec 22

Vita Life Sciences Limited's (ASX:VLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Nov 19

Vita Life Sciences Limited's (ASX:VLS) Prospects Need A Boost To Lift Shares

Jul 14

Ripartizione dei ricavi e delle spese

Come Vita Life Sciences guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

ASX:VLS Ricavi, spese e utili (AUD Millions )
Data	Ricavi	Guadagni	Spese G+A
31 Dec 23	74	9	31
30 Sep 23	72	8	30
30 Jun 23	69	7	29
31 Mar 23	68	7	29
31 Dec 22	67	7	29
30 Sep 22	65	8	27
30 Jun 22	64	8	26
31 Mar 22	61	8	25
31 Dec 21	57	8	24
30 Sep 21	54	8	23
30 Jun 21	50	7	22
31 Mar 21	48	6	22
31 Dec 20	46	6	21
30 Sep 20	46	6	22
30 Jun 20	45	5	22
31 Mar 20	44	4	23
31 Dec 19	42	3	23
30 Sep 19	42	2	23
30 Jun 19	41	2	23
31 Mar 19	41	2	22
31 Dec 18	41	2	21
30 Sep 18	40	3	21
30 Jun 18	40	4	21
31 Mar 18	38	3	20
31 Dec 17	37	3	20
30 Sep 17	37	3	20
30 Jun 17	37	3	20
31 Mar 17	38	3	20
31 Dec 16	38	3	20
30 Sep 16	38	4	20
30 Jun 16	38	5	20
31 Mar 16	39	5	21
31 Dec 15	39	4	21
30 Sep 15	38	4	20
30 Jun 15	37	4	20
31 Mar 15	37	6	20
31 Dec 14	37	7	19
30 Sep 14	36	7	19
30 Jun 14	36	7	19
31 Mar 14	36	6	19
31 Dec 13	35	5	18
30 Sep 13	34	4	18

Guadagni di qualità: VLS ha guadagni di alta qualità.

Margine di profitto in crescita: VLS's current net profit margins (12.2%) are higher than last year (10.6%).

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: VLS's earnings have grown significantly by 23.9% per year over the past 5 years.

Accelerare la crescita: VLS's earnings growth over the past year (28.2%) exceeds its 5-year average (23.9% per year).

Guadagni vs Settore: La crescita degli utili VLS nell'ultimo anno ( 28.2% ) ha superato la percentuale del settore Pharmaceuticals 28.2%.

Vita Life Sciences Performance dei guadagni passati

Il passato criteri di controllo 6/6

Informazioni chiave

Aggiornamenti sulle prestazioni recenti

Full year 2023 earnings released: EPS: AU$0.17 (vs AU$0.13 in FY 2022)

First half 2023 earnings released: EPS: AU$0.074 (vs AU$0.069 in 1H 2022)

Full year 2022 earnings released: EPS: AU$0.13 (vs AU$0.16 in FY 2021)

First half 2022 earnings released: EPS: AU$0.069 (vs AU$0.07 in 1H 2021)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

First half 2021 earnings released: EPS AU$0.07 (vs AU$0.058 in 1H 2020)

Recent updates

Now 22% undervalued

Non-Executive Chairman recently sold AU$654k worth of stock

New minor risk - Insider selling

MD & Director recently sold AU$1.9m worth of stock

Vita Life Sciences Limited (ASX:VLS) Stock Catapults 26% Though Its Price And Business Still Lag The Market

Upcoming dividend of AU$0.06 per share

Vita Life Sciences (ASX:VLS) Has Announced That It Will Be Increasing Its Dividend To A$0.06

Vita Life Sciences Limited, Annual General Meeting, May 15, 2024

Vita Life Sciences' (ASX:VLS) Shareholders Will Receive A Bigger Dividend Than Last Year

Final dividend increased to AU$0.06

Full year 2023 earnings released: EPS: AU$0.17 (vs AU$0.13 in FY 2022)

New minor risk - Insider selling

Vita Life Sciences Limited Provides Earnings Guidance for the Full Year Ending December 31, 2023

Upcoming dividend of AU$0.03 per share at 3.7% yield

First half 2023 earnings released: EPS: AU$0.074 (vs AU$0.069 in 1H 2022)

Vita Life Sciences Limited Announces Interim Dividend for the Six Months Ended June 30, 2023, 6 October 2023

Vita Life Sciences Limited Appoints Peter Osborne as an Independent Non-Executive Director

Investor sentiment improves as stock rises 15%

Upcoming dividend of AU$0.033 per share at 3.9% yield

Full year 2022 earnings released: EPS: AU$0.13 (vs AU$0.16 in FY 2021)

No independent directors

A Look At The Fair Value Of Vita Life Sciences Limited (ASX:VLS)

Vita Life Sciences Provides Earnings Guidance for the Full Year Ending 31 December 2022

No independent directors

Vita Life Sciences Limited Announces Board Changes, Effective 30 September 2022

Upcoming dividend of AU$0.028 per share

Vita Life Sciences Limited Declares Fully Franked Interim Dividend for the Six Months Ended June 30, 2022, Payable on 7 October 2022

First half 2022 earnings released: EPS: AU$0.069 (vs AU$0.07 in 1H 2021)

Vita Life Sciences Limited Provides Earnings Guidance for the Half Year Ending June 30, 2022

Non-Executive Chairman exercised options to buy AU$433k worth of stock.

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Upcoming dividend of AU$0.03 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Vita Life Sciences Limited Announces Dividend for Six Months Ended December 31, 2021, Payable on April 7, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of AU$0.028 per share

Should You Be Adding Vita Life Sciences (ASX:VLS) To Your Watchlist Today?

First half 2021 earnings released: EPS AU$0.07 (vs AU$0.058 in 1H 2020)

Independent Non-Executive Director Jonathan Tooth has left the company

Investor sentiment improved over the past week

Vita Life Sciences Limited Provides Earnings Guidance for the Half Year Ending June 30, 2021

If You Like EPS Growth Then Check Out Vita Life Sciences (ASX:VLS) Before It's Too Late

Full year 2020 earnings released: EPS AU$0.12 (vs AU$0.057 in FY 2019)

Did Vita Life Sciences' (ASX:VLS) Share Price Deserve to Gain 83%?

Investor sentiment improved over the past week

Upcoming Dividend of AU$0.028 Per Share

Full year 2020 earnings released: EPS AU$0.12 (vs AU$0.057 in FY 2019)

Vita Life Sciences Limited (ASX:VLS) On An Uptrend: Could Fundamentals Be Driving The Stock?

Vita Life Sciences (ASX:VLS) Is Growing Earnings But Are They A Good Guide?

Here's Why We Think Vita Life Sciences (ASX:VLS) Is Well Worth Watching

New 90-day high: AU$1.00

Vita Life Sciences Limited's (ASX:VLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Upcoming Dividend of AU$0.015 Per Share

New 90-day high - AU$0.95

First half earnings released

New 90-day high - AU$0.70

Vita Life Sciences Limited's (ASX:VLS) Prospects Need A Boost To Lift Shares

Ripartizione dei ricavi e delle spese

Storia dei guadagni e delle entrate

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Rendimento del capitale proprio

Rendimento delle attività

Rendimento del capitale investito

Scoprire le aziende con forti performance passate